Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Shahir Kassam-Adams will join the Company as Chief Strategy Officer. Mr. Kassam-Adams comes to Decision Resources from Thomson Healthcare where he was an Executive Vice President managing Thomson's $250 million clinical decision support businesses which include PDR, Micromedex, and MercuryMD. Prior to that role, he held leading strategic positions at both Thomson Healthcare and Elsevier Science.

Mr. Kassam-Adams will be responsible for managing Decision Resources aggressive acquisition plans. The Company's growth strategy has recently been accelerated by new owner Providence Equity Partners. Decision Resources announced it was being acquired by Providence in May of 2007. The Company had previously been owned by private equity firms Castanea Partners and Boston Ventures.

"We are excited that Shahir will be joining our team," said Peter Hoenigsberg, CEO of Decision Resources. "Bringing someone with Shahir's experience and caliber to Decision Resources is indicative of our aggressive growth strategy. He will be instrumental in achieving our ambitious growth plans utilizing Providence's abundant capital, his sector expertise and our own talented pool of employees."

Mr. Hoenigsberg and Mr. Kassam-Adams previously worked together at Harcourt, Inc. Mr. Kassam-Adams was the Executive Vice President for Strategic Development for the Scientific, Technical, and Medical Group at Harcourt.

About Decision Resources, Inc.

Decision Resources, Inc. is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The Company currently has three business units including HealthLeaders-InterStudy, the leading provider of managed care industry intelligence; Millennium Research Group, the global authority on medical device market intelligence; and Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues. You can visit the companies' web sites at,, and

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Decision Resources, Inc.   Elizabeth Marshall   781-296-2563 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc., +1-781-296-

Lack of Available Patients for Testing Limits Development of Breast Cancer Drugs

View Now